CanSino Biologics Inc (CJH) - Total Liabilities

Latest as of June 2025: €2.80 Billion EUR ≈ $3.28 Billion USD

Based on the latest financial reports, CanSino Biologics Inc (CJH) has total liabilities worth €2.80 Billion EUR (≈ $3.28 Billion USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore CanSino Biologics Inc (CJH) cash conversion ratio to assess how effectively this company generates cash.

CanSino Biologics Inc - Total Liabilities Trend (2016–2024)

This chart illustrates how CanSino Biologics Inc's total liabilities have evolved over time, based on quarterly financial data. Check CanSino Biologics Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.

CanSino Biologics Inc Competitors by Total Liabilities

The table below lists competitors of CanSino Biologics Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Jiangsu Newamstar Packaging Machinery Co Ltd SHE:300509	China	CN¥1.94 Billion
Vinte Viviendas Integrales S.A.B. de C.V MX:VINTE	Mexico	MX$18.35 Billion
PostNL NV AS:PNL	Netherlands	€1.86 Billion
Zhejiang Wandekai Fluid Equipment Technology Co. Ltd. A SHE:301309	China	CN¥235.94 Million
Johnson Outdoors Inc NASDAQ:JOUT	USA	$186.58 Million
Hollyland China Electronics Technology Corp Ltd SHE:002729	China	CN¥102.81 Million
First Trust High Yield Opportunities 2027 Term Fund NYSE:FTHY	USA	$192.09 Million
Ventec International Group Co Ltd TW:6672	Taiwan	NT$1.43 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down CanSino Biologics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see CanSino Biologics Inc (CJH) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.46	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.57	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.36	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how CanSino Biologics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for CanSino Biologics Inc (2016–2024)

The table below shows the annual total liabilities of CanSino Biologics Inc from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	€3.05 Billion ≈ $3.56 Billion	-24.39%
2023-12-31	€4.03 Billion ≈ $4.71 Billion	-4.55%
2022-12-31	€4.22 Billion ≈ $4.94 Billion	+26.97%
2021-12-31	€3.33 Billion ≈ $3.89 Billion	+391.17%
2020-12-31	€677.22 Million ≈ $791.74 Million	+115.69%
2019-12-31	€313.98 Million ≈ $367.08 Million	+6.96%
2018-12-31	€293.56 Million ≈ $343.20 Million	+13.33%
2017-12-31	€259.03 Million ≈ $302.84 Million	+131.90%
2016-12-31	€111.70 Million ≈ $130.59 Million	--

About CanSino Biologics Inc

F:CJH Germany Drug Manufacturers - Specialty & Generic

Market Cap

$493.24 Million

€421.89 Million EUR

Market Cap Rank

#12607 Global

#1337 in Germany

Share Price

€3.18

Change (1 day)

-0.63%

52-Week Range

€3.18 - €5.95

All Time High

€45.99